Phosphoproteome profiling reveals critical role of JAK-STAT signaling in maintaining chemoresistance in breast cancer.

Nascimento AS, Peres LL, Fari AVS, Milani R, Silva RA, da Costa Fernandes CJ, Peppelenbosch MP, Ferreira-Halder CV, Zambuzzi WF

Open source

DOI: 10.18632/oncotarget.21801
Published: 2017 Dec 29
Container: Oncotarget
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.18632/oncotarget.21801,
  title = {Phosphoproteome profiling reveals critical role of JAK-STAT signaling in maintaining chemoresistance in breast cancer.},
  author = {Nascimento AS and Peres LL and Fari AVS and Milani R and Silva RA and da Costa Fernandes CJ and Peppelenbosch MP and Ferreira-Halder CV and Zambuzzi WF},
  year = {2017},
  journal = {Oncotarget},
  doi = {10.18632/oncotarget.21801},
  url = {https://doi.org/10.18632/oncotarget.21801}
}

RIS

TY  - JOUR
TI  - Phosphoproteome profiling reveals critical role of JAK-STAT signaling in maintaining chemoresistance in breast cancer.
AU  - Nascimento AS
AU  - Peres LL
AU  - Fari AVS
AU  - Milani R
AU  - Silva RA
AU  - da Costa Fernandes CJ
AU  - Peppelenbosch MP
AU  - Ferreira-Halder CV
AU  - Zambuzzi WF
PY  - 2017
JO  - Oncotarget
DO  - 10.18632/oncotarget.21801
UR  - https://doi.org/10.18632/oncotarget.21801
ER  -

APA

AS, N., LL, P., AVS, F., R, M., RA, S., CJ, D. C. F., MP, P., CV, F., & WF, Z. (2017). Phosphoproteome profiling reveals critical role of JAK-STAT signaling in maintaining chemoresistance in breast cancer.. Oncotarget. https://doi.org/10.18632/oncotarget.21801

Source records

pubmed · retrieved 2026-09-26T08:51:24.731Z